Adapting to a changing landscape: switching to oncology biosimilars

Adapting to a changing landscape: switching to oncology biosimilars

Emma Foreman, Philippe Arnaud, Glenn Myers
Discussing the primary considerations involved in switching from an originator biologic pharmaceutical product to a biosimilar product.
Watch now
Empowering patients as part of a successful biosimilar switching strategy

Empowering patients as part of a successful biosimilar switching strategy

Emma Foreman, María-José Tamés
Discussing the importance of patient education concerning treatment regimens involving biosimilars with real-world examples.
Watch now
Implementing biosimilars: a case study on pharmacovigilance best practice

Implementing biosimilars: a case study on pharmacovigilance best practice

Glenn Myers, Marta Trojniak
Discussing the added importance of pharmacovigilance during treatment with biosimilars with real-world examples.
Watch now

Other educational activities

Real world evidence: Abstract library

Summaries of the latest published papers, data and real-world evidence

Real word evidence: case studies

Enhance your learnings on the use of biosimilars and test your knowledge with our mini-quizzes

View chapters

Enhance your learnings on the use of biosimilars and test your knowledge with our mini-quizzes